Solid Tumors
A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)
- Details
ClinicalTrials.gov ID:
NCT04083976
Diagnosis Type:
NA
USOR Number:
- Address
3144 Horizon Rd, Suite 110
Rockwall, TX 75032
P: (972) 771-3322